1. Home
  2. CODX vs PLUR Comparison

CODX vs PLUR Comparison

Compare CODX & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • PLUR
  • Stock Information
  • Founded
  • CODX 2013
  • PLUR 2001
  • Country
  • CODX United States
  • PLUR Israel
  • Employees
  • CODX N/A
  • PLUR N/A
  • Industry
  • CODX Medical/Dental Instruments
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CODX Health Care
  • PLUR Health Care
  • Exchange
  • CODX Nasdaq
  • PLUR Nasdaq
  • Market Cap
  • CODX 22.0M
  • PLUR 24.9M
  • IPO Year
  • CODX 2017
  • PLUR N/A
  • Fundamental
  • Price
  • CODX $0.71
  • PLUR $4.33
  • Analyst Decision
  • CODX Hold
  • PLUR
  • Analyst Count
  • CODX 1
  • PLUR 0
  • Target Price
  • CODX $1.50
  • PLUR N/A
  • AVG Volume (30 Days)
  • CODX 139.9K
  • PLUR 6.8K
  • Earning Date
  • CODX 03-13-2025
  • PLUR 02-11-2025
  • Dividend Yield
  • CODX N/A
  • PLUR N/A
  • EPS Growth
  • CODX N/A
  • PLUR N/A
  • EPS
  • CODX N/A
  • PLUR N/A
  • Revenue
  • CODX $7,321,012.00
  • PLUR $678,000.00
  • Revenue This Year
  • CODX N/A
  • PLUR N/A
  • Revenue Next Year
  • CODX N/A
  • PLUR N/A
  • P/E Ratio
  • CODX N/A
  • PLUR N/A
  • Revenue Growth
  • CODX 57.16
  • PLUR 89.92
  • 52 Week Low
  • CODX $0.65
  • PLUR $4.07
  • 52 Week High
  • CODX $2.23
  • PLUR $8.48
  • Technical
  • Relative Strength Index (RSI)
  • CODX 43.93
  • PLUR 45.34
  • Support Level
  • CODX $0.69
  • PLUR $4.45
  • Resistance Level
  • CODX $0.73
  • PLUR $4.78
  • Average True Range (ATR)
  • CODX 0.04
  • PLUR 0.20
  • MACD
  • CODX 0.00
  • PLUR 0.01
  • Stochastic Oscillator
  • CODX 42.31
  • PLUR 17.86

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.

Share on Social Networks: